Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Theranostics 2013; 3(12):943-952. doi:10.7150/thno.7445 This issue Cite

Review

Micro-RNAs as Potential New Molecular Biomarkers in Oncology: Have They Reached Relevance for the Clinical Imaging Sciences?

Frank Berger✉, Maximilian F. Reiser

Department for Clinical Radiology, Ludwig-Maximilians-University, Campus Innenstadt, Nussbaumstrasse 20, 80336 Munich, Germany

✉ Corresponding author: Frank Berger M.D. Department for Clinical Radiology, Ludwig-Maximilians-University, Campus Innenstadt, Nussbaumstrasse 20, 80336 Munich, Germany. Phone: +49-89-5160-9201. Email: Frank.Bergeruni-muenchen.de

Citation:
Berger F, Reiser MF. Micro-RNAs as Potential New Molecular Biomarkers in Oncology: Have They Reached Relevance for the Clinical Imaging Sciences?. Theranostics 2013; 3(12):943-952. doi:10.7150/thno.7445. https://www.thno.org/v03p0943.htm
Other styles

File import instruction

Abstract

Minimally invasive biomarkers for early cancer detection and monitoring of personalized therapies are of high importance to further improve prognosis in oncological disease. MicroRNAs (miRNAs) are small regulatory RNAs in humans and play a key role in carcinogenesis. In recent years they have emerged as promising biomarkers in oncology. miRNA profiling has demonstrated its capacity for sub-classifying tumors and monitoring of therapeutic effects. Different expression profiles of miRNAs in cancer and the stability of circulating miRNAs potentially provide a clinically accessible molecular monitoring tool of malignant tissues and its response to therapies. Clinical imaging including the modalities PET/CT and MRI is well established for characterizing tumor tissue and sub-classifying morphological, metabolic or vascular treatment response in cancer. Sophisticated clinical imaging biomarkers for cancer detection and monitoring should now been correlatively applied to further validate the potential of miRNAs as oncologic biomarkers for the clinic.

Keywords: MicroRNA, Treatment Monitoring, Personalized Therapy, Cancer Imaging, Biomarker

Citation styles

APA
Berger, F., Reiser, M.F. (2013). Micro-RNAs as Potential New Molecular Biomarkers in Oncology: Have They Reached Relevance for the Clinical Imaging Sciences?. Theranostics, 3(12), 943-952. https://doi.org/10.7150/thno.7445.

ACS
Berger, F.; Reiser, M.F. Micro-RNAs as Potential New Molecular Biomarkers in Oncology: Have They Reached Relevance for the Clinical Imaging Sciences?. Theranostics 2013, 3 (12), 943-952. DOI: 10.7150/thno.7445.

NLM
Berger F, Reiser MF. Micro-RNAs as Potential New Molecular Biomarkers in Oncology: Have They Reached Relevance for the Clinical Imaging Sciences?. Theranostics 2013; 3(12):943-952. doi:10.7150/thno.7445. https://www.thno.org/v03p0943.htm

CSE
Berger F, Reiser MF. 2013. Micro-RNAs as Potential New Molecular Biomarkers in Oncology: Have They Reached Relevance for the Clinical Imaging Sciences?. Theranostics. 3(12):943-952.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use